阻断XIAP:CASP7-p19通过一种新型可逆小分子选择性诱导CASP3/DR恶性瘤的亡
Shih-Hsun Chen1, Szu-Ying Wu2, Yun-Xun Chang2
1Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan. shichen@ntu.edu.tw.
Cell death & disease
|June 18, 2025
概括
研究人员确定了一种新的可逆抑制剂643943,向XIAP:CASP7相互作用. 这种化合物选择性地杀死具有低卡斯巴-3水平的耐药癌细胞,为特定恶性瘤提供了一种新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与X相关的亡抑制剂 (XIAP) 是亡的一个关键调节剂,抑制亡. caspases.
- 通过对抗XIAP,Smac模仿剂正在被研究用于癌症治疗.
- 准XIAP:CASP7相互作用是一种克服化学抵抗的策略,特别是在caspase-3下调调节 (CASP3/DR) 癌症中.
研究的目的:
- 为了确定XIAP:CASP7蛋白质-蛋白质相互作用的可逆抑制剂.
- 评估已识别的抑制剂在杀死耐药癌细胞中的有效性.
- 阐明新型抑制剂的作用机制和治疗潜力.
主要方法:
- 多模式虚拟查以识别潜在的抑制剂.
- 在体外实验评估化合物结合,酶激活和细胞毒性.
- 在体内研究以评估抗癌疗效.
- 对化学抵抗机制的分析,包括β-catenin和ABC运输体.
主要成果:
- 确定了一个可逆的XIAP:CASP7抑制剂,643943.
- 643943 在体外和体内选择性杀死CASP3/DR癌细胞系 (例如,MCF-7).
- 该化合物的结合方式和细胞毒性通过结构修改得到证实.
- 643943通过降低β-catenin和ABC载体的调节来克服帕克利塔塞尔耐药性.
结论:
- XIAP:CASP7是癌症治疗的可行的药物标.
- 643943是第一个可逆的XIAP:CASP7抑制剂,具有治疗CASP3/DR恶性瘤的潜力.
- 这一发现为克服特定癌症类型的化学抵抗提供了新的治疗途径.
相关概念视频
Caspases
12.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


